Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Summit stock falls as Akeso shares bispecific OS data vs. Keytruda
Summit’s stock price plummeted by nearly 37% following Akeso’s overall survival reveal before a trading halt was initiated.
Angus Liu
Apr 25, 2025 4:02pm
AbbVie plots $10B US outlay as pharma tariff threat looms
Apr 25, 2025 11:52am
Akeso CEO tries to reset expectations of bispecific's OS readout
Apr 28, 2025 6:50am
J&J puts ImmunityBio on defense mode in bladder cancer
Apr 27, 2025 12:35pm
Amgen blueprints $900M expansion at Ohio biomanufacturing plant
Apr 25, 2025 2:43pm
Gilead stands by long-acting PrEP launch amid policy uncertainties
Apr 25, 2025 11:29am
More News
Akeso’s Anniko enters crowded US PD-1 market
Apr 25, 2025 10:55am
Compounders ordered to halt production of semaglutide knockoffs
Apr 25, 2025 10:25am
Angus on Angus: A Fierce oncology discussion
Apr 25, 2025 9:41am
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Apr 25, 2025 8:45am
